Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins

Published:2019-06-26 Issue:8 Volume:16 Page:3544-3558
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Klesmith Justin R.¹^ORCID,Su Lihe²,Wu Lan²,Schrack Ian A.¹,Dufort Fay J.²,Birt Alyssa²,Ambrose Christine²,Hackel Benjamin J.¹^ORCID,Lobb Roy R.²,Rennert Paul D.²

Affiliation:

1. Department of Chemical Engineering and Materials Science, University of Minnesota Twin Cities, 421 Washington Avenue SE, Minneapolis, Minnesota 55455, United States

2. Aleta Biotherapeutics, 27 Strathmore Road, Natick, Massachusetts 01760, United States

Funder

Aleta Biotherapeutics

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b00418

Reference60 articles.

1. CAR T cell immunotherapy for human cancer

2. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

3. FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma

4. Chimeric Antigen Receptor Therapy

5. Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiscale photocatalytic proximity labeling reveals cell surface neighbors on and between cells;Science;2024-07-19

2. Yeast-based screening platforms to understand and improve human health;Trends in Biotechnology;2024-04

3. Sequence-developability mapping of affibody and fibronectin paratopes via library-scale variant characterization;Protein Engineering, Design and Selection;2024

4. ProteinGym: Large-Scale Benchmarks for Protein Design and Fitness Prediction;2023-12-08

5. Engineered yeast cells simulating CD19+ cancers to control CAR T cell activation;2023-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3